Congress passed the Food and Drug Administration Safety and Innovation Act this week, but did not include a provision aimed at improving supply chain safety. Among other things, the legislation will "for the first time, enable the FDA to: regularly inspect foreign drug manufacturing facilities, which supply 80 percent of the ingredients in our medications," said Allan Coukell, director of medical programs at the Pew Health Group. But UPS spokesman Kara Gerhardt Ross sa...